Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Effect of Initial Central Sensitization Severity on Treatment Response in Patients With Fibromyalgia

NCT05020600 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT05020600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05020600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Effect of Initial Central Sensitization Severity on Treatment Response in Patients With Fibromyalgia
Lead sponsor
Marmara University
Phase
Observational
Overall status
Unknown status
Start date
August 19, 2021
Completion date
December 1, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central sensitisation, fibromyalgia